Julià Blanco

Associate Professor

Universitat de Vic - Universitat Central de Catalunya

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

ORCID

Google Scholar

About

Julià Blanco is an Associate Professor at Universitat de Vic - Universitat Central de Catalunya in Spain. His research focuses on immunology and virology, particularly in relation to SARS-CoV-2 and HIV. Recent articles include investigations into COVID-19 convalescent plasma therapy and post-vaccination immune responses. He is also involved in developing novel immunogens and assessing the safety and efficacy of vaccines against emerging variants.

Julià Blanco

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections

Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study

Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trial

Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species

Rethinking Optimal Immunogens to Face SARS‐CoV‐2 Evolution Through Vaccination

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention

Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides

Production and characterization of novel Anti-HIV Fc-fusion proteins in plant-based systems: Nicotiana benthamiana &amp; tobacco BY-2 cell suspension

NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

Collaborators (12)

Josep Vidal-Alaball

Patricia Resa-Infante

Guillem Pera

Carlota Dobaño Lazaro

Raúl Pérez Caballero

Eva Riveira Muñoz

Luis M Molinos-Albert

Maria Jose Forner Giner

Julia G Prado

Leire de Campos Mata

Carlo Carolis

Pere-Joan Cardona

How do I reach out?

Meet Kite AI

Production and characterization of novel Anti-HIV Fc-fusion proteins in plant-based systems: Nicotiana benthamiana & tobacco BY-2 cell suspension